A recent study published in Alimentary Pharmacology and Therapeutics reports that patients with a lower hepatitis B virus (HBV) haplotype number of less than or equal to two are more likely to achieve ...
The ability of A2-derived HBV vaccines to protect against non-A2 HBV genotypes has recently been brought into question following the publication of a study of 3.7 million blood donors in the USA. [25] ...
All currently available genetically engineered HBV vaccines use the A2 genotype, serotype adw. A study showing occult HBV infections in US blood donors demonstrated that none of the unvaccinated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results